• Publications
  • Influence
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.
Background Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain. MethodsExpand
  • 2,278
  • 79
  • PDF
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden ofExpand
  • 3,230
  • 37
  • PDF
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
Summary Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015Expand
  • 2,991
  • 34
  • PDF
Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): A systematic review.
BACKGROUND Current knowledge of angiolymphoid hyperplasia with eosinophilia (ALHE) derives from retrospective reports and case series, leading to a nonevidence-based treatment approach. OBJECTIVEExpand
  • 53
  • 14
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
BACKGROUND Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers ofExpand
  • 635
  • 13
  • PDF
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
  • Marissa B Nancy Marie Joseph S Amanuel Kalkidan Hassen Cri Reitsma Fullman Ng Salama Abajobir Abate Abbafati , M. Reitsma, +231 authors E. Gakidou
  • Medicine
  • The Lancet
  • 13 May 2017
Summary Background The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remainsExpand
  • 680
  • 13
  • PDF
Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study.
BACKGROUND Little is known about the epidemiology of eczema in adults. The goal of this study was to determine the prevalence of and associations with adult eczema in the United States. METHODS WeExpand
  • 318
  • 12
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
BACKGROUND Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 andExpand
  • 470
  • 10
  • PDF
Baricitinib in adult patients with moderate‐to‐severe atopic dermatitis: A phase 2 parallel, double‐blinded, randomized placebo‐controlled multiple‐dose study
Background: Baricitinib, an oral selective inhibitor of Janus kinase 1 and Janus kinase 2, modulates proinflammatory cytokine signaling. Objectives: The efficacy and safety of baricitinib wereExpand
  • 132
  • 9
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of
Summary Background Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments ofExpand
  • 1,095
  • 7
  • PDF